| 000 | 01802 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516020403.0 | ||
| 264 | 0 | _c20110527 | |
| 008 | 201105s 0 0 eng d | ||
| 022 | _a1557-8852 | ||
| 024 | 7 |
_a10.1089/cbr.2010.0813 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avon Guggenberg, Elisabeth | |
| 245 | 0 | 0 |
_aIn vitro characterization of two novel biodegradable vectors for the delivery of radiolabeled antisense oligonucleotides. _h[electronic resource] |
| 260 |
_bCancer biotherapy & radiopharmaceuticals _cDec 2010 |
||
| 300 |
_a723-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p21 _xgenetics |
| 650 | 0 | 4 | _aEndocytosis |
| 650 | 0 | 4 |
_aEthylenediamines _xchemistry |
| 650 | 0 | 4 |
_aFluorine Radioisotopes _xchemistry |
| 650 | 0 | 4 | _aGamma Rays |
| 650 | 0 | 4 |
_aGene Expression _xradiation effects |
| 650 | 0 | 4 | _aGene Transfer Techniques |
| 650 | 0 | 4 | _aHCT116 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIsotope Labeling |
| 650 | 0 | 4 |
_aLactones _xchemistry |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xadministration & dosage |
| 650 | 0 | 4 |
_aPhosphatidylethanolamines _xchemistry |
| 650 | 0 | 4 |
_aPhosphorothioate Oligonucleotides _xadministration & dosage |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xchemistry |
| 650 | 0 | 4 |
_aPolymers _xchemistry |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xadministration & dosage |
| 650 | 0 | 4 |
_aSpermine _xchemistry |
| 700 | 1 | _aShahhosseini, Soraya | |
| 700 | 1 | _aKoslowsky, Ingrid | |
| 700 | 1 | _aLavasanifar, Afsaneh | |
| 700 | 1 | _aMurray, David | |
| 700 | 1 | _aMercer, John | |
| 773 | 0 |
_tCancer biotherapy & radiopharmaceuticals _gvol. 25 _gno. 6 _gp. 723-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/cbr.2010.0813 _zAvailable from publisher's website |
| 999 |
_c20490496 _d20490496 |
||